Yahoo Finance 
Global Companion Animal Ear Infection Treatment (Otitis Externa, Otitis Media) Market Size, Share & Trends Analysis Report 2021-2028
Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Companion Animal Ear Infection Treatment Market Size, Share & Trends Analysis Report by Disease Type (Otitis Externa, Otitis Media), by Product, by Mode of Administration, by Animal Type, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
The global companion animal ear infection treatment market size is expected to reach USD 877.3 million by 2028 and is expected to expand at a CAGR of 6.56% from 2021 to 2028
The increasing prevalence of ear infections in companion animals is one of the factors responsible for the market growth. An ear infection is a second-most common condition in canines. Otitis Externa is a common disorder and one of the top reasons for increase dvet visits.
The COVID-19 pandemic acted as a catalyst for rapid business and economic changes. Moreover, popular trends, such as "bring your pet to work", are also supporting the market growth. Companies operating in this market are widely accepting different approaches to treat otitis in companion animals. For instance, in April 2020, VirbacintroducedEasotic, a prescription medicine specified for the topical treatment of otitis externa in canines.
The rising number of pet owners and awareness about animal health and hygiene will boost the market growth. For instance, as stated by the American Pet Products Association's National Pet Owners Survey 2019-2020, 63.4 million U.S. households own dogs.
Thus, increasing pet ownership along with growing research & development activities in animal health accelerates the market growth. For example, Dechra Pharmaceuticals spent USD 40.31 million (£28.4 million) on R&D in 2020, while USD 35.62 million (£28.4 million) in 2019. Moreover, the humanization of pets further contributes to market growth.
Companion Animal Ear Infection Treatment Market Report Highlights
The anti-bacterial product segment accounted for the largest revenue share in 2020 and will retain the leading position throughout the forecast period
This growth can be credited to the rising incidence of ear diseases in pets associated with the bacterial infection
The topical segment is anticipated to have significant growth owing to the availability of a wide range of products and high demand for topical treatments
The cats animal type segment is estimated to register the fastest CAGR from 2021 to 2028 owing to increased concerns regarding the health and hygiene of cats
The otitis externa disease segment is projected to register considerable growth as it is one of the most common and recurrent problems
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Companion Animal Ear Infection Treatment Market Variables, Trends & Scope
Chapter 4 Covid-19 Impact Analysis
Chapter 5 Companion Animal Ear Infection Treatment Market - Competitive Analysis
Chapter 6 Companion Animal Ear Infection Treatment Market: Product Estimates & Trend Analysis
Chapter 7 Companion Animal Ear Infection Treatment Market: Disease Type Estimates & Trend Analysis
Chapter 8 Companion Animal Ear Infection Treatment Market: Mode of Administration Estimates and Trend Analysis
Chapter 9 Companion Animal Ear Infection Treatment Market: Animal Type Estimates and Trend Analysis
Chapter 10 Companion Animal Ear Infection Treatment Market: Regional Estimates & Trend Analysis
Chapter 11 Company Profiles
Zoetis
Elanco
Dechra Pharmaceuticals
Merck & Co., Inc
Virbac
Vetoquinol
Penn Veterinary Supply, Inc.
Ceva Sante Animale
Vedco, Inc
For more information about this report visit https://www.researchandmarkets.com/r/tv8r7j
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
